San Francisco, California
London, United Kingdom
Chief Science Officers and Chief Medical Officers have a tough job—organizing and managing R&D uncovering new disruptive discovery and development models; assessing the impact of pricing, reimbursement, and regulation—all while raising capital, working with investors, and strategizing appropriate exits.
NewYorkBIO’s CSO Leadership Series is designed to help bioscience CSO/CMOs to engage with experienced industry leaders and address the unique challenges associated with the job. Attendees will gain guidance on strategic planning, exit planning, and insight into the trends affecting the future of medical research in the emerging life science space.
Limited to 25 attendees, the CSO Leadership Series is restricted to life science executives (no service providers beyond the sponsor) and will offer a unique opportunity to hear directly from—and to network with—New York’s life science leadership.
Exclusive CEO Leadership Series Sponsor
September 11, 2014
Judith Dunn, PhD
VP, Global Head Clinical Development
Head of Roche Innovation Center, New York City
Judy joined Roche in 2010 as part of PD Neuroscience. She founded the Development Integration Team which facilitates early scientific collaboration between the REDs and PD. Judy moved to pRED in 2013 to Head the Roche Innovation Center New York, and in 2014 she assumed the role of Global Head of Clinical Development. Prior to Roche, Judy held positions in the research and commercial divisions of Pfizer, led Psychiatry Clinical Development at Sepracor, and served as Vice President of Clinical Research at Flexion, a biotech company. Judy has a keen interest in methodology and holds leadership positions in several external societies focused on improving the drug development paradigm. Judy attended Wesleyan University and the University of Rochester, obtaining undergraduate and graduate degrees in Neurobiology. She was recipient of a Research Fellowship in Neuropharmacology from the Center for Brain Research at Strong Memorial Hospital as well as a Postdoctoral Fellowship in Clinical Research from Pfizer.